Avadel Pharmaceuticals PLC (AD - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AVDL Nasdaq 2834 https://www.avadel.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Avadel Pharmaceuticals PLC (AD

Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results - Mar 30th, 2023 11:00 am
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2022 Financial Results on March 30 - Mar 30th, 2023 1:27 am
Avadel Pharmaceuticals Announces Pricing of Public Offering of ADSs and Series B Preferred Shares - Mar 30th, 2023 1:24 am
Avadel Pharmaceuticals Announces Proposed Underwritten Public Offering of ADSs and Series B Preferred Shares - Mar 29th, 2023 8:13 pm
Avadel Pharmaceuticals Enters into Royalty Agreement with RTW Investments for up to $75 Million - Mar 29th, 2023 8:01 pm
Avadel Pharmaceuticals Announces FDA Authorization to Import Tentatively-Approved LUMRYZ™ Ahead of Anticipated Final Approval Decision - Mar 22nd, 2023 11:00 am
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Mar 21st, 2023 8:05 pm
Avadel Pharmaceuticals Requests Final FDA Approval for LUMRYZ™ (sodium oxybate) extended-release oral suspension - Mar 2nd, 2023 12:00 pm
Avadel Pharmaceuticals Shows Big Promise -- And Risk - Feb 28th, 2023 3:37 pm
UPDATE 2-Jazz Pharma ruling clears U.S. roadblock for rival narcolepsy drug - Feb 24th, 2023 9:16 pm
Jazz Pharma ruling clears U.S. roadblock for rival narcolepsy drug - Feb 24th, 2023 8:51 pm
Avadel Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference - Feb 8th, 2023 1:00 pm
Avadel Pharmaceuticals Announces Publication of Real-World Data Highlighting the Risk of Accidental Dosing Errors with Immediate-Release Twice-Nightly Oxybates - Jan 24th, 2023 1:00 pm
Avadel Pharmaceuticals plc (NASDAQ:AVDL) insiders placed bullish bets worth US$677k in the last 12 months - Nov 26th, 2022 12:49 pm
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences - Nov 22nd, 2022 1:00 pm
Analyst Bumps Up Price Target For Avadel Pharmaceuticals After Favorable Patent Ruling - Nov 21st, 2022 7:32 pm
Avadel Pharmaceuticals Announces Favorable Ruling Regarding Sleep Disorder Drug Patent - Nov 21st, 2022 1:40 pm
Avadel Pharmaceuticals Announces Favorable Ruling on Motion to Delist REMS Patent from FDA’s Orange Book - Nov 18th, 2022 7:45 pm
Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference - Nov 10th, 2022 1:00 pm
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2022 Financial Results - Nov 9th, 2022 12:30 pm